Adam was born in Houston, Texas. He was admitted to the Bar in 1991 and is licensed to practice in the courts of the State of Texas and the United States District Court for the Southern District of Texas.
Pharmaceutical & Medical Device Litigation, Insurance Litigation, Product Liability Litigation, Personal Injury Litigation, and Consumer Fraud
B.A. University of Texas, 1987;
J.D. University of Houston Law Center, 1990;
Law Review, South Texas College of Law, 1988.
American Association for Justice (AAJ)
Texas Trial Lawyers Association (TTLA)
Houston Trial Lawyers Association (HTLA)
American Bar Association (ABA)
National Trial Lawyers Association (NTLA)
For the last 30 years Adam has represented his clients from coast to coast, and against some of the largest corporations and law firms in the country. The clients of the firm and the attorneys who currently make up Pulaski Law Firm have received over $7 billion in settlements. Adam has successfully represented clients against corporations like Eli Lilly, Equifax, General Motors (GM), GSK, Johnson & Johnson, Stryker, Target, Toys“R”Us, Volkswagen, and Zimmer. Further, he has successfully represented clients against some of the largest insurance carriers in the country, and abroad. Currently, Adam is litigating active dockets against GSK, Pfizer, Boehringer Ingelheim, Sanofi, Chubb, Lloyd’s of London, State Farm, FM Global and others. In May 2020, Adam was appointed Co-Lead Counsel of MDL 2924 in the Southern District of Florida by Judge Robin Rosenberg. Further, Adam sits on the Plaintiffs’ Steering Committee for the state court consolidation representing his clients against the manufacturer of JUUL.
